Robbie B Mailliard

8PUBLICATIONS
39CO-AUTHORS
Cellular immunologyInnate immunityMolecular targetsMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 03, 2026
Type 1-polarized DC immunotherapeutic contains heterogeneous populations with IL-12p70 production restricted to a rare subset.

|May 15, 2026
Induction of HIV-Specific T Cell Responses Using αDC1 Pulsed With Conserved HIV-1 Peptides.

|Dec 04, 2025
Pancreatic Cancer Organoids Recapitulate Chemotherapy Response and Identify a Potent Cytotoxic T-Cell Population.

Renee R Anderko, Alexandra E Bowman, Praneel Murthy

|Mar 29, 2024
Persistence of a Skewed Repertoire of NK Cells in People with HIV-1 on Long-Term Antiretroviral Therapy.

Renee R Anderko, Allison E DePuyt, Rhianna Bronson

|Dec 22, 2020
The Unknown Unknowns: Recovering Gamma-Delta T Cells for Control of Human Immunodeficiency Virus (HIV).

Shivkumar Biradar, Michael T Lotze, Robbie B Mailliard

|Nov 14, 2020
IL-18 Responsiveness Defines Limitations in Immune Help for Specialized FcRγ- NK Cells.

Renee R Anderko, Charles R Rinaldo, Robbie B Mailliard

Pageof 2

Frequent Collaborators

3 joint publications

Renee R Anderko

3 joint publications

Charles R Rinaldo

2 joint publications

Allison E DePuyt

1 joint publications

Kai Qin